The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Estrone-Global Market Insights and Sales Trends 2024
Synopsis
Estrone (E1), also spelled oestrone, is a steroid, a weak estrogen, and a minor female sex hormone.
The global Estrone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Estrone in various end use industries. The expanding demands from the Pharmaceutical and Biological Research, are propelling Estrone market. Purity: <99%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity: ≥99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Estrone market, driven by demand from China, the second largest economy with some signs of stabilising, the Estrone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Estrone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Estrone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Estrone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Estrone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Estrone covered in this report include Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, etc.
The global Estrone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Global Estrone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Estrone market, Segment by Type:
Purity: <99%
Purity: ≥99%
Global Estrone market, by Application
Pharmaceutical
Biological Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Estrone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Estrone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Estrone (E1), also spelled oestrone, is a steroid, a weak estrogen, and a minor female sex hormone.
The global Estrone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Estrone in various end use industries. The expanding demands from the Pharmaceutical and Biological Research, are propelling Estrone market. Purity: <99%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity: ≥99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Estrone market, driven by demand from China, the second largest economy with some signs of stabilising, the Estrone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Estrone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Estrone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Estrone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Estrone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Estrone covered in this report include Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, etc.
The global Estrone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Global Estrone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Estrone market, Segment by Type:
Purity: <99%
Purity: ≥99%
Global Estrone market, by Application
Pharmaceutical
Biological Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Estrone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Estrone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Estrone Market Overview
1.1 Estrone Product Overview
1.2 Estrone Market Segment by Type
1.2.1 Purity: <99%
1.2.2 Purity: ≥99%
1.3 Global Estrone Market Size by Type
1.3.1 Global Estrone Market Size Overview by Type (2018-2029)
1.3.2 Global Estrone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Estrone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Estrone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Estrone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Estrone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Estrone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Estrone Sales Breakdown by Type (2018-2023)
2 Global Estrone Market Competition by Company
2.1 Global Top Players by Estrone Sales (2018-2023)
2.2 Global Top Players by Estrone Revenue (2018-2023)
2.3 Global Top Players by Estrone Price (2018-2023)
2.4 Global Top Manufacturers Estrone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Estrone Market Competitive Situation and Trends
2.5.1 Estrone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Estrone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Estrone as of 2022)
2.7 Date of Key Manufacturers Enter into Estrone Market
2.8 Key Manufacturers Estrone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Estrone Status and Outlook by Region
3.1 Global Estrone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Estrone Historic Market Size by Region
3.2.1 Global Estrone Sales in Volume by Region (2018-2023)
3.2.2 Global Estrone Sales in Value by Region (2018-2023)
3.2.3 Global Estrone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Estrone Forecasted Market Size by Region
3.3.1 Global Estrone Sales in Volume by Region (2024-2029)
3.3.2 Global Estrone Sales in Value by Region (2024-2029)
3.3.3 Global Estrone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Estrone by Application
4.1 Estrone Market Segment by Application
4.1.1 Pharmaceutical
4.1.2 Biological Research
4.2 Global Estrone Market Size by Application
4.2.1 Global Estrone Market Size Overview by Application (2018-2029)
4.2.2 Global Estrone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Estrone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Estrone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Estrone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Estrone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Estrone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Estrone Sales Breakdown by Application (2018-2023)
5 North America Estrone by Country
5.1 North America Estrone Historic Market Size by Country
5.1.1 North America Estrone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Estrone Sales in Volume by Country (2018-2023)
5.1.3 North America Estrone Sales in Value by Country (2018-2023)
5.2 North America Estrone Forecasted Market Size by Country
5.2.1 North America Estrone Sales in Volume by Country (2024-2029)
5.2.2 North America Estrone Sales in Value by Country (2024-2029)
6 Europe Estrone by Country
6.1 Europe Estrone Historic Market Size by Country
6.1.1 Europe Estrone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Estrone Sales in Volume by Country (2018-2023)
6.1.3 Europe Estrone Sales in Value by Country (2018-2023)
6.2 Europe Estrone Forecasted Market Size by Country
6.2.1 Europe Estrone Sales in Volume by Country (2024-2029)
6.2.2 Europe Estrone Sales in Value by Country (2024-2029)
7 Asia-Pacific Estrone by Region
7.1 Asia-Pacific Estrone Historic Market Size by Region
7.1.1 Asia-Pacific Estrone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Estrone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Estrone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Estrone Forecasted Market Size by Region
7.2.1 Asia-Pacific Estrone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Estrone Sales in Value by Region (2024-2029)
8 Latin America Estrone by Country
8.1 Latin America Estrone Historic Market Size by Country
8.1.1 Latin America Estrone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Estrone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Estrone Sales in Value by Country (2018-2023)
8.2 Latin America Estrone Forecasted Market Size by Country
8.2.1 Latin America Estrone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Estrone Sales in Value by Country (2024-2029)
9 Middle East and Africa Estrone by Country
9.1 Middle East and Africa Estrone Historic Market Size by Country
9.1.1 Middle East and Africa Estrone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Estrone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Estrone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Estrone Forecasted Market Size by Country
9.2.1 Middle East and Africa Estrone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Estrone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Jiangxi Yuneng Pharmaceutical
10.1.1 Jiangxi Yuneng Pharmaceutical Company Information
10.1.2 Jiangxi Yuneng Pharmaceutical Introduction and Business Overview
10.1.3 Jiangxi Yuneng Pharmaceutical Estrone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Jiangxi Yuneng Pharmaceutical Estrone Products Offered
10.1.5 Jiangxi Yuneng Pharmaceutical Recent Development
10.2 Shanghai Lianlu Industry
10.2.1 Shanghai Lianlu Industry Company Information
10.2.2 Shanghai Lianlu Industry Introduction and Business Overview
10.2.3 Shanghai Lianlu Industry Estrone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Shanghai Lianlu Industry Estrone Products Offered
10.2.5 Shanghai Lianlu Industry Recent Development
10.3 Jiangsu Yuanda SYM Pharmaceutical
10.3.1 Jiangsu Yuanda SYM Pharmaceutical Company Information
10.3.2 Jiangsu Yuanda SYM Pharmaceutical Introduction and Business Overview
10.3.3 Jiangsu Yuanda SYM Pharmaceutical Estrone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jiangsu Yuanda SYM Pharmaceutical Estrone Products Offered
10.3.5 Jiangsu Yuanda SYM Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Estrone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Estrone Industrial Chain Analysis
11.4 Estrone Market Dynamics
11.4.1 Estrone Industry Trends
11.4.2 Estrone Market Drivers
11.4.3 Estrone Market Challenges
11.4.4 Estrone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Estrone Distributors
12.3 Estrone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
